Israeli pharmaceutical giant Teva said Monday that it was buying the generic drug business of Allergan for $40.5 billion, consolidating its position as a world leader in generics.
Teva will pay $33.75 billion in cash and offer $6.75 billion of its stock to Allergan, the company said, in a major move that will further shake up the industry.
GMT 21:55 2018 Tuesday ,23 January
Trump to meet May, Netanyahu, Kagame in Davos: White HouseGMT 21:53 2018 Tuesday ,23 January
S&P 500, Nasdaq end at records as technology shares gainGMT 21:51 2018 Tuesday ,23 January
Venezuela's Maduro says ready to run for second termGMT 21:49 2018 Tuesday ,23 January
Trump to tell Erdogan of concern over Syria offensiveGMT 21:47 2018 Tuesday ,23 January
Trump says NAFTA talks are 'moving along pretty well'GMT 22:13 2018 Monday ,22 January
Senate votes to end US shutdown, bill heads to HouseGMT 22:12 2018 Monday ,22 January
Dow, S&P, Nasdaq finish at records as US goverment shutdown endsGMT 22:10 2018 Monday ,22 January
Turkish soldier killed in Syria operationMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2023 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2023 ©